JUL 13, 2016 08:33 AM PDT

Itaconate Metabolite Hijacks Macrophage Activation

WRITTEN BY: Kara Marker
Macrophages of the immune system are vital for mounting a quick and directed attack on invading pathogens especially along the inflammatory pathway, but often overzealous macrophages can go a bit too far and cause damage with excessive inflammation. Numerous immune suppression therapies exist on the market, but often they can render a person vulnerable to infection while trying to relieve an inflammatory disorder. A new option has surfaced in a new study: a natural metabolite that controls macrophage activity.
 Draw-bridge depicts Itaconate disrupting the TCA cycle flow - Credit: Aleksandra Ziminova
A collaboration of scientists from Washington University, ITMO University, McGill University, and the Max Planck Institute of Immunobiology and Epigenetics is behind the potential new option for suppressing inflammation: itaconate. Their findings were recently published in the journal Cell Metabolism.
 
Macrophages transition between three distinct stages during their lifetime: neutral (M0), pro-inflammatory (M1), and anti-inflammatory (M2). As expected, M1 macrophages are the type that arrives first at the scene of the crime, promoting inflammation to begin the immune attack on whatever pathogen has invaded the body. When a M1 macrophage becomes “overly diligent” though, numerous pathologies can result: cardiac ischemia, metabolic disorders, and even autoimmune diseases.
 
Too much inflammation is dangerous and leads to these diseases because of the absorption of energy resources required to keep the inflammatory pathway up and running. The new study looked at the transition process of macrophages between states, especially between their inactive and pro-inflammatory state. This is where itaconate comes into the picture, a natural metabolite released by macrophages whose role scientists have never quite understood – until now.
 
The researchers found that there seems to be a defined limit of the amount of itaconate that can be produced during the M0 – M1 transition, and as itaconate levels grow closer to the limit, macrophage activation to its pro-inflammatory state is designed to fail. “Itaconate sets the bar controlling M1 macrophage formation, said Alexey Sergushichev, one of the study’s authors.
 
Itaconate’s role within macrophage activation was finally realized when the researchers connected the metabolite to the bodily processes for producing energy from glucose oxidation: cellular respiration and the tricarboxylic acid cycle. An enzyme called succinate dehydrogenase (SDH) provides a component called fumarate to the tricarboxylic acid cycle. This is where the researchers saw itaconate interfering with energy production: itaconate blocks the enzyme entirely.
 
With the tricarboxylic acid cycle and cellular respiration halted without a necessary enzyme, macrophage activation to a pro-inflammatory state fails. In this way, itaconate acts as an anti-inflammatory agent, while it also acts as an antioxidant by blocking glucose oxidation.
 
The successful breakdown of itaconate and its role in macrophage activation is important for understanding how inflammatory diseases develop, as well as for how to treat them. Sergushichev believes that this new insight will lead to the ability of scientists to “artificially manipulate the transition of macrophages from M0 to M1, meaning the possibility of restraining inflammations.”
 


Sources: ITMO University, Current Opinion in Plant Biology
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 26, 2018
Immunology
SEP 26, 2018
Is Good Bacteria Still Good?
A team of researchers looks at the effects of probiotics on the guts ability to reconstitute a microbiome after antibiotic treatment....
OCT 11, 2018
Cell & Molecular Biology
OCT 11, 2018
Revealing a 'Double Agent' in the Immune System
Researchers want to enhance our natural defenses to fight a variety of health problems more effectively....
OCT 29, 2018
Immunology
OCT 29, 2018
Escape of the Tumor Cell
Tumor cells in breast cancer have proven to evade the immune responses utilizing actin cytoskeleton...
NOV 14, 2018
Immunology
NOV 14, 2018
Reversing T Cell dysfunction in Cancer: Getting the Body to Fight its own Battles
Using the power of the immune system to eliminate cancerous cells has long the been the goal of immuno-oncology. Immune cells naturally recognize, destroy,...
NOV 27, 2018
Immunology
NOV 27, 2018
A Mutated Immunity
Researchers utilize blood samples to determine cancer neoantigens to create effective vaccination in mouse model...
DEC 18, 2018
Health & Medicine
DEC 18, 2018
Mapping the Human Proteome
Advancing our understanding of human disease often requires a sound understanding of normal human physiology. A critical tool to provide guidance on human...
Loading Comments...